• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
GHSI

GHSI

Guardion Health Sciences, Inc.

OTCHealthcareDrug Manufacturers - Specialty & GenericUS

USD3.25

+0.03 (+0.93%)

Company Profile

CEO

Mark Goldstone

IPO Date

2019-04-05

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

OTC

Country

US

Market Metrics

Open

$3.25

Prev. Close

$3.22

Day Low

$3.25

Day High

$3.25

52W Low

$3.04

52W High

$18.00

Market Cap

$0.00B

Volume

0.00M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

49.7%

Avg Negative

1.3%

Avg Neutral

48.9%

News Feed

Guardion Health Sciences to Exhibit at the American Society of Cataract and Refractive Surgery Annual Meeting

GlobeNewsWire·7/22/2021·↑ positive

Acquiring Activ Nutritional Is Perfect for Growth, Says Guardion Health Sciences

Benzinga·6/25/2021·↑ positive

Guardion Health Sciences to Be Added to the Russell 3000 Index

GlobeNewsWire
·6/14/2021
·↑ positive

Guardion Health Sciences Announces Appointment of Craig J. Sheehan as Chief Commercial Officer

GlobeNewsWire·6/3/2021·↑ positive

Guardion Health Sciences Broadens Clinical Nutrition Product Offerings by Closing Acquisition of Activ Nutritional, which owns the Science Backed, Revenue-Generating Viactiv® Product Line, from Adare Pharmaceuticals

GlobeNewsWire·6/2/2021·↑ positive

Guardion Health Sciences to Present at the LD Micro Virtual Invitational Conference on June 9, 2021

GlobeNewsWire·6/2/2021·↑ positive

Guardion Health Sciences (GHSI) Stock: Over 8% Increase Explanation

Pulse2·5/18/2021·↑ positive

Guardion Health Sciences to Acquire Activ Nutritional, LLC and Its Well-Known Viactiv® Brand of Products from Adare Pharmaceuticals, Inc.

GlobeNewsWire·5/18/2021·↑ positive

Guardion Health Sciences Initiates Placebo-Controlled Clinical Trial Involving Proprietary GlaucoCetin® Product

GlobeNewsWire·5/3/2021·↑ positive

Guardion Health Sciences Announces Financial Results for the Three Months and Year Ended December 31, 2020

GlobeNewsWire·3/26/2021·↑ positive